yth2206游艇会
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.10.30
关于会计政策变更的公告
2019.10.30
第四届监事会第二十次会议决议公告
2019.10.29
2019年面向合格投资者公开发行公司债券(第一期)发行结果公告
2019.10.25
2019年面向合格投资者公开发行公司债券(第一期)票面利率公告
2019.10.25
2019年面向合格投资者公开发行公司债券(第一期)发行相关情况的调整公告
2019.10.24
2019年公开发行公司债券(第一期)募集说明书摘要(面向合格投资者)
2019.10.24
2019年公开发行公司债券(第一期)募集说明书(面向合格投资者)
2019.10.24
2019年面向合格投资者公开发行公司债券(第一期)发行公告
2019.10.24
2019年公开发行公司债券(第一期)信用评级报告
2019.10.15
2019年前三季度业绩预告
第一页
上一页
43
44
45
46
47
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.